S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial.
about
Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer-a systematic review.Docetaxel/S-1 Versus Docetaxel/Capecitabine as First-Line Treatment for Advanced Breast Cancer: A Retrospective Study.Synergistic Effect of SH003 and Doxorubicin in Triple-negative Breast Cancer.ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cellsConcurrent radiotherapy with S-1 plus cisplatin versus concurrent radiotherapy with cisplatin alone for the treatment of locally advanced cervical carcinoma: a pilot randomised controlled trial.
P2860
S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
S-1 combined with docetaxel fo ...... breast cancer: phase II trial.
@ast
S-1 combined with docetaxel fo ...... breast cancer: phase II trial.
@en
type
label
S-1 combined with docetaxel fo ...... breast cancer: phase II trial.
@ast
S-1 combined with docetaxel fo ...... breast cancer: phase II trial.
@en
prefLabel
S-1 combined with docetaxel fo ...... breast cancer: phase II trial.
@ast
S-1 combined with docetaxel fo ...... breast cancer: phase II trial.
@en
P2093
P2860
P50
P356
P1433
P1476
S-1 combined with docetaxel fo ...... breast cancer: phase II trial.
@en
P2093
Joo-Hang Kim
Seung Il Kim
Soohyeon Lee
Yong Wha Moon
P2860
P2888
P356
10.1186/1471-2407-13-583
P407
P577
2013-12-06T00:00:00Z
P5875
P6179
1017278092